ClinicalTrials.gg
Not yet recruitingNCT07920536Updated Nov 5, 2026

Evaluation of Exercise With Overdressing to Induce Heat Acclimation in an Average Fitness Warfighter

An interventional study of Exercise + overdressing in Heat Acclimation and Thermotolerance, sponsored by United States Army Research Institute of Environmental Medicine. Not yet recruiting. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by United States Army Research Institute of Environmental Medicine · Not applicable, Interventional, and Treatment

Updated Nov 5, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

A randomized, crossover trial examining five days of exercise \& standardized overdressing versus exercise alone.

Read the detailed description

The purpose of this study is to determine the efficacy of five training sessions with overdressing + exercise to induce heat acclimation in individuals with standard fitness levels. Fifteen fit (capable of running 2 miles in 17-20 min), healthy adults will complete 90 minutes of exercise (including running at 6.0mph for up to 15 minutes at 0-1% grade, and walking at 3.5mph for up to 75 minutes at grades ranging from 0%-5%) on five occasions at room tempertature (\~20°C, \~50% RH, 1 mph air velocity). Participants will be randomized to begin in either the overdressing + exercise or standard PT clothing group and complete the study in a crossover manner. Heat acclimation induction will be assessed using standardized heat stress tests (HSTs) performed before and after five training sessions. After the final HST has occurred, participants will complete a minimum 4-week washout and then return to repeat the identical protocol in the opposite configuration (overdressing vs. PT clothing).

02

Conditions studied

  • Heat Acclimation and Thermotolerance

Keywords

  • thermoregulation
  • adaptation
03

In context

Lead sponsor

United States Army Research Institute of Environmental Medicine is the lead sponsor of 68 studies on the registry; 7 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female, age 18-45 (17 if active-duty military).
  • In good health as determined by the Office of Medical Support \& Oversight (OMSO) General Medical Clearance.
  • Performs aerobic exercise at least 2 times per week and 2 mile run time is between 14:30 and 20:00 minutes.
  • Willing to abstain from exercise and alcoholic beverages for 24 hours before each study visit.
  • Willing to abstain from caffeine for 12 hours prior to all study visits.
  • Willing to abstain from food for 2 hours prior to all study visits.
  • Have supervisor approval if permanent party military or a federal employee at U.S. Army Natick Soldier System Center.

Exclusion criteria

Exclusion Criteria:

  • Frequent hot bath or sauna users (e.g., more than three times a week for the past month).
  • Females who are pregnant or planning to become pregnant during the study.
  • Females who are menopausal or
  • Taking dietary supplements, prescriptions, or over the counter medication, other than a (unless approved by OMSO \& PI).
  • Any nicotine or recreational drug use (unless quit 1 month prior to the start of the study)
  • Abnormal blood count during OMSO medical screening (For example: (Hb) outside of the typical normal values reported by LabCorp in accordance with OMSO (Normal [Hb] Males = 12.6-17.7 g/dL; Females = 11.1-15.9 g/dL) or hematocrit (Hct) outside of the normal ranges (Normal Hct Males = 37.5-51.0%; Females = 34.0-46.6%) levels, presence of abnormal blood chemicals (hemoglobin S or sickle cell traits).
  • Any history of pulmonary, cardiovascular, or renal disease (unless approved by OMSO \& PI).
  • Uncontrolled asthma.
  • Current or recent respiratory tract or sinus infections (\< 2 weeks prior).
  • Blood donation (i.e., 550 mL whole blood) during the study or 8 weeks before and after the study
  • History of heat stroke or orthostatic intolerance.
  • Diagnosed and/or treated for fluid/electrolyte imbalance within the last 30 days.
  • History of obstructive disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis.
  • Scheduled MRI during testing.
  • Allergies to adhesives (e.g., medical tape).
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Exercise first

    Five days of exercise alone followed by four week washout then exercise + overdressing

    Other: Exercise + overdressing

  • Experimental
    Exercise + Overdressing first

    Exercise + overdressing following by four week washout and exercise alone

    Other: Exercise + overdressing

Interventions

  • OtherExercise + overdressing

    Standardized exercise with multiple layers of clothing to stimulate heat loss mechanisms and elicit adaptations

06

What researchers measure

Primary outcomes

  1. Core temperature change

    Change in core temperature following exercise alone and exercise + overdressing

    Time frame: 7 days

  2. Heart rate change

    Change in heart rate following exercise alone and exercise + overdressing

    Time frame: 7 days

  3. Skin temperature change

    Change in skin temperature following exercise alone and exercise + overdressing

    Time frame: 7 days

  4. Sweating rate change

    Change in sweating rate following exercise alone and exercise + overdressing

    Time frame: 7 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Greenfield AM, Brazelton SC, Alba BK, Bodurtha PO, Bradbury KE, Caldwell AR, Chapman CL, Charkoudian N, Connor KR, Conz K, Fry BA, Giersch GEW, Gonzalez-Rojas DH, Heikkinen ME, Looney DP, Mayer TA, McCarthy KG, Potter AW, Rioux TP, Salgado RM, Seeley AD, Shaw MA, Xu X, Ryan BJ. Exercise with overdressing for heat acclimation: a multilayered approach using biophysical modeling and two randomized crossover trials. J Appl Physiol (1985). 2025 Oct 1;139(4):889-901. doi: 10.1152/japplphysiol.00624.2025. Epub 2025 Sep 5. PubMed 40912903 ↗

Individual participant data

Plan to share: No — Cannot share military personnel IDP and some proportion of volunteers will be US Servicemembers.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Apr 2028, 17 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2026
First posted
Nov 5, 2026
StartEst.
Nov 2026
Primary completionEst.
Apr 2028
CompletionEst.
Jun 2028
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07920536
Lead sponsor
United States Army Research Institute of Environmental Medicine
Responsible party
Gabrielle Giersch (Research Physiologist, United States Army Research Institute of Environmental Medicine) — Principal investigator
First posted
Nov 5, 2026
Start date
Nov 2026 (estimated)
Primary completion
Apr 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Nov 5, 2026

Study contacts

Gabrielle E Giersch, PhD
Contact
gabrielle.e.giersch.civ@health.mil
508-206-2421

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion